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Abstract
Mitogen-activated protein (MAP) kinases are activated by dual-specificity kinases, termed MEKs. Using MEK2 as bait in
yeast two-hybrid screening, besides c-Raf and KSR, A-Raf was identified as a novel partner that interacts with MEK2. This
interaction was confirmed by in vitro binding assay. Further investigation indicates that regions critical for this interaction
were located between residues 255 and 606 that represent the kinase domain of A-Raf. ß 2002 Elsevier Science B.V. All
rights reserved.
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1. Introduction
Mitogen-activated protein kinase (MAPK) cascade
consists of a three-kinase module: MAPK, MAPK
kinase (MEK), and MAPK kinase kinase
(MAPKKK or MEKK) [1^3]. This pathway is acti-
vated by growth factors and mitogens, results in the
activation of diverse biological processes including
¢broblastic cell proliferation and transformation [4^
6], Xenopus oocyte maturation [7], PC12 cell di¡er-
entiation [5], and metaphase II arrest of unfertilized
eggs [8,9]. MAP kinase activation requires phosphor-
ylation on both tyrosine and threonine residues [10^
12], reactions that are catalyzed by dual-speci¢city
kinases named MEKs. The extracellular signal-regu-
lated kinase (MAPKerk) pathway is the best de-
scribed MAPK signaling pathway in mammalian
cells. Two di¡erent MEK cDNAs, MEK1 and
MEK2, that are considered to be involved in the
MAPKerk pathway, have been isolated from several
species [13^15]. MEK1 and MEK2 are the only two
identi¢ed ERK activators. The human MEK1 and
MEK2 encode 393 and 400 amino acid residues re-
spectively and function as dual threonine/tyrosine ki-
nase. They are highly homologous in primary amino
acid sequence, sharing 80% identity. The amino acid
sequence comparison of MEK1 and MEK2 indicates
that the N-terminal region is not conserved [14]. The
transfection analysis and biochemical reconstitution
in vitro indicate that Raf kinase can activate MEK1
and MEK2 [16]. Although Tetsuo et al. have proved
that the two isoforms of MEK were activated in the
same manner in response to NGF and EGF [17],
there are several conditions where MEK1 and
MEK2 appear to be di¡erentially regulated. Cells
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transformed by oncogenic forms of Ras display in-
creased MEK1 activity compared with MEK2, sug-
gesting that Ras and Raf preferentially signal to
ERK1/2 via MEK1 [16,18].
Ligation of many receptors leads to the activation
of ERK1/2 through the activation of the Ras-Raf-
MAPK pathway. Raf is the immediate upstream ac-
tivator of MEK and is the dominant element
through which RTK (receptor tyrosine kinase)-acti-
vated Ras gains control of MEK. c-Raf-1 was iso-
lated as the ¢rst member of a family of cytoplasmic
serine/threonine kinases, which now contains three
members: A-Raf, c-Raf, and B-Raf. The three Raf
isoforms share a comparable structure. They contain
three conserved regions, CR1, CR2, and CR3, which
are embedded in variable regions [19]. CR3 repre-
sents the N-terminal kinase domain, which is highly
conserved among the three isoforms; CR1 and CR2
belong to the N-terminal regulatory domain, which is
less conserved. The conservation of a particular iso-
form between di¡erent species is higher than that
between isoforms within a single species [20]. This
clearly indicates that the distinct roles for the indi-
vidual Raf isoforms have evolved.
B-Raf and c-Raf were found to activate both
MEK1 and MEK2 [21,22], whereas A-Raf was
only found to activate MEK1 [23]. To further eluci-
date the mechanisms by which MEK2 is regulated,
we undertook studies to identify proteins that inter-
act with MEK2. Here we report the interaction be-
tween A-Raf and MEK2 detected in a two-hybrid
system.
2. Materials and methods
2.1. Plasmid construction for the yeast two-hybrid
system and yeast two-hybrid library screening
Oligonucleotide primers 5P-gatgaattcatgctggcccg-
gaggaagccgaa-3P and 5P-gatctcgagtcacacggcggtgcgcg-
tggg-3P were used in PCRs to amplify the 1200 bp
coding sequence of human MEK2 gene [14]. PCR
products were cut with EcoRI and XhoI restriction
enzymes (Gibco) and subsequently cloned into
pLexA (ClonTech) as the bait. The cloning junction
was sequenced to con¢rm the fusion. The interaction
trap assay [24] was performed using the MATCH-
MAKER LexA Two-Hybrid System (ClonTech).
The procedure was described in the user manual.
Brie£y, the pLexA-A-Raf was transformed into yeast
strain EGY48(p8op-lacZ) using the lithium acetate
procedure and plated onto minimal synthetic drop-
out medium (SD medium) (Ura3, His3), and grown
at 30‡C for 3^5 days. A human fetal liver cDNA
library (ClonTech) with 5U106 independent inserts
cloned in pB42AD was then transformed into the
yeast strain containing the MEK2 bait plasmid and
plated on SD medium (Ura3, His3 and Trp3). A
total of 5U106 primary yeast transformants were
scraped, pooled and stored at 370‡C. The ampli¢ed
yeast cotransformants were plated onto SD induc-
tion medium (SD/Gal/Raf, SD medium containing
galactose, ra⁄nose and X-gal) (Ura3, His3, Trp3,
Leu3). Four days later, plasmids from clones that
grew on SD induction medium and turned blue
were isolated as described by Ho¡man and Winston
[25] and introduced into Escherichia coli strain KC8
cells (ClonTech) by electroporation. Library plas-
mids were selected by plating the transformation
mix onto a plate containing ampicillin, uracil, histi-
dine and leucine, but lacking tryptophan. cDNAs
were ¢rst analyzed by restriction mapping using
EcoRI and XhoI enzymes and sorted into groups
depending on their restriction map pattern. At least
one representative cDNA from each class was parti-
ally automated sequenced using a 310 Genetic Ana-
lyzer (PE Applied Biosystems). Sequence homology
searches were done using the basic BLAST search
tools of NCBI (National Center for Biotechnology
Information).
For directed interaction tests, yeast strain EGY48
was cotransformed with A-Raf deletion constructs
and MEK2. Transformants were then handled as
previously described.
2.2. In vitro binding
MEK2 was cloned into pcDNA3; A-Raf and its
deletion constructs, A-Raf(1^261) and A-Raf(255^
606), were cloned into pcDNA3-GST respectively.
Their transcripts were produced by an in vitro tran-
scription kit (Promega) according to the user man-
ual. Rabbit reticulocyte lysates from Promega were
used to generate [35S]Met-labeled proteins, which
were used immediately for binding studies. The bind-
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ing reactions were performed in NETN bu¡er (0.5%
Nonidet P-40, 20 mM Tris (pH 8.0), 1 mM EDTA,
100 mM NaCl) at 4‡C for 4 h with constant mixing.
The beads were washed three times with the same
bu¡er, and the bound proteins were subjected to




A yeast two-hybrid screen was used to identify
proteins that interact with MEK2. We plated a
pool of cells that contained 5U107 original cotrans-
formants at a multiplicity of 10 onto induction me-
dium. Approx. 50 clones were obtained whose LEU2
and lacZ reporter genes were activated. These clones
were considered to contain interacting partners of
MEK2. To further verify this interaction, the library
plasmid was isolated and simultaneously cotrans-
formed with pLexA-MEK2 and with pLexA as a
negative control. Among these library plasmids there
were 39 clones, which could activate both the LEU2
and the lacZ reporter gene when they cotransfected
with pLexA-MEK2, but not when they cotransfected
with pLexA only. Restriction mapping showed that
these clones could be sorted into seven groups. At
least one representative cDNA from each class was
partially sequenced. Our sequence homology search
identi¢ed the encoded proteins. The positive clones
include A-Raf, Ksr and c-Raf. All these peptides are
in-frame to the invariant amino-terminal moiety of
the vector-encoded protein. Besides these clones that
code for proteins that have been well characterized,
there were clones whose cDNA sequences were de-
posited in GenBank as EST but their properties were
as yet unknown (GenBank accession Nos. AI174218,
AI193260, AA323625 and AL042845), but the de¢-
nition of these EST indicates that they are similar to
proto-oncogene Raf, KSR and MAPKK2 respec-
tively.
The A-Raf clone contained full-length cDNA,
whereas MEK2, Ksr and c-Raf contained only a
3P-part of the cDNA. In the case of MEK2, it started
with the codon for amino acid 267, while in the case
of Ksr, it started with the codon for amino acid 300,
and in the case of c-Raf, with the codon for amino
acid 234. Within these proteins, A-Raf was a new
partner that interacts with MEK2. To eliminate a
false positive, we moved the A-Raf from the
PB42AD to the pLexA vector and handled MEK2
vice versa. Cotransformants containing the switched
plasmids could also activate the report genes (Fig. 1).
This con¢rmed the interaction between MEK2 and
A-Raf.
3.2. In vitro binding assay
Since a yeast protein could have mediated the sig-
nal in the two-hybrid assay, we sought to con¢rm the
interaction detected in the two-hybrid system with a
biochemical assay. In vitro expression plasmids
pcDNA3-GST-A-Raf, pcDNA3-GST-A-Raf(1^261),
pcDNA3-GST-A-Raf(255^606) and pcDNA3-
MEK2 were generated as described in Section 2. In
vitro translated, [35S]Met-labeled full-length MEK2
Fig. 1. A-Raf interacts with protein isolated from the library.
Individual colonies of EGY48 yeast cells containing positive
control (1), negative control (2), pLexA-MEK2 and PB42AD-
A-Raf (3), pLexA-MEK2 and PB42AD-Lamin C as control (4),
pLexA-A-Raf and PB42AD-MEK2 (5), pLexA-A-Raf and
PB42AD-Lamin C as control (6), were streaked with toothpicks
onto a SD induction plate (His3, Ura3, Trp3, Leu3 containing
X-gal). Interaction results in the activation of LEU2 and lacZ
report genes, the positive colonies can grow in the absence of
leucine and turn blue. The positive control and the negative
control were provided with the yeast two-hybrid system kit.
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and glutathione beads were incubated with [35S]-
Met-labeled GST-A-Raf, GST-A-Raf(1^261) and
GST-A-Raf(255^606) respectively. The beads were
then washed, and the bound polypeptides were sub-
jected to SDS^PAGE analysis. The results showed
that MEK2 could interact with A-Raf and it bound
speci¢cally to the kinase domain of A-Raf but not to
the regular domain of A-Raf (Fig. 2).
3.3. Interaction of A-Raf with MEK2
Several A-Raf deletion mutants (1^162, 1^261,
255^606) were tested in order to map the speci¢c
sites required for the interaction (Fig. 3). Direct
two-hybrid tests were performed using the full-length
MEK2 and the di¡erent A-Raf deletion constructs.
The deletion mutant A-Raf (255^606) did reveal in-
teraction with MEK2, but the C-terminal part, A-
Raf (1^261), has lost this ability.
4. Discussion
We used the yeast two-hybrid system to detect
proteins that may interact with MEK2. Besides Ksr
and c-Raf, that have been found to interact with
MEK2 [26,27], A-Raf was identi¢ed as a new partner
of MEK2. The site responsible for the interaction
was mapped to the kinase domain of A-Raf.
The MAP kinase cascade involves at least three
protein kinases that function in series and these three
enzymes comprise a module. The identi¢cation of
upstream regulators and downstream e¡ectors of
each component is a challenge for signal transduc-
tion research. The yeast two-hybrid system has been
successfully used to identify many di¡erent types of
protein^protein interactions [22,28,29]. Although it
has been reported that when using wild type
MEK1 and MEK5 as the bait to screen the HeLa
cell cDNA library by the yeast two-hybrid system, no
Fig. 3. Interaction of MEK2 with A-Raf and mapping of the binding region. In direct two-hybrid tests, the interaction between the
full length of MEK2 and di¡erent A-Raf constructs was examined by activation of the LEU2 and lacZ reporter genes. +, both report-
er genes were activated; 3, neither of the reporter genes was activated. RBD is in black and CRD is in white. RBD, Ras binding do-
main; CRD, cysteine-rich domain. The numbers above refer to amino acids.
Fig. 2. MEK2 interacts with A-Raf in vitro. The in vitro trans-
lated [35S]MEK2 and glutathione Sepharose beads were incu-
bated with [35S]GST-A-Raf, [35S]GST-A-Raf(1^261) and
[35S]GST-A-Raf(255^606), respectively. The bound proteins
were analyzed by autoradiography after SDS^PAGE. Lanes:
1, 10% input of the in vitro translated [35S]GST-A-Raf(255^606);
2, 10% input of the in vitro translated [35S]GST-A-Raf(1^261);
3, 10% input of the in vitro translated [35S]MEK2; 4, interac-
tion of GST-A-Raf(1^261) with MEK2; 5, interaction of GST-
A-Raf(255^606) with MEK2; 6, interaction of GST-A-Raf with
MEK2; 7, 10% input of the in vitro translated [35S]GST-A-Raf.
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positive clone was found due to the unstable form of
the protein complex [23], Schae¡er et al. isolated
MP1 from the mouse lymphoma cDNA library using
wild type MEK1 as the bait [30]. It seems that at
least some types of protein complex formed during
the signal transduction are stable enough to be de-
tected using the yeast two-hybrid system. Based on
this rationale, we successfully isolated A-Raf kinase
using the wild type MEK2. Since it has been proved
that under certain conditions MEK2 could not be
activated by A-Raf [23], it is also plausible that
A-Raf does not phosphorylate MEK2 so that it
could form a stable complex with MEK2 and be
detected in our experiments.
The Raf family contains three members: A-Raf,
B-Raf and c-Raf [19]. Although there is clear evi-
dence for the overlap of the three Raf isoforms in
the ability to activate the classical cytoplasmic cas-
cade [31], evidence that arose from the structure and
expression pattern analysis indicates the speci¢c roles
for each isoform. In RasL61-transformed NIH3T3
cells c-Raf is activated through tyrosine phosphory-
lation, while B-Raf activity is only little a¡ected [32].
In NIH3T3 cells, B-Raf was strongly activated by H-
Ras G12R while c-Raf and A-Raf are only weakly
activated [33]. The di¡erent responses of PC12 cells
under EGF and NGF stimulation are due to the
di¡erence in the activation kinetics of A-Raf, B-Raf
and c-Raf during EGF and NGF treatment [34]. As
to MEK1 and MEK2, there are also several condi-
tions where they appear to be di¡erentially regulated.
For example, when recombinant Ras-GTP is used to
bind e¡ectors from cell lysates, a complex of c-Raf
and MEK1 or B-Raf and MEK1 is found, while no
complex that involves MEK2 is isolated [18].
Although there is clearly an overlap of the three
Raf isozymes and the two MEK isoforms in the abil-
ity to activate the classical cytoplasmic cascade
[18,31], they are not redundant. So many experi-
ments have indicated the speci¢c roles for each iso-
form in the regulation of cell proliferation and di¡er-
entiation. The speci¢city of MAPK responses will be
achieved by the selective activation of di¡erent Raf-
MEK-MAPK modules in response to di¡erent stim-
uli. Recently sca¡old protein was found to play an
important role in the organization of a speci¢c
MAPK pathway [35]. So, A-Raf may interact with
MEK2 and phosphorylate it during certain stimu-
lation. Although it has been reported that A-Raf
could not activate MEK2 in EGF stimulated HeLa
cells [23], there are two possible reasons. First, under
this circumstance, A-Raf was not selected to trans-
duce the signal, perhaps only c-Raf or B-Raf was
used. Second, with the help of a sca¡old protein,
MEK2 may have activated a speci¢c downstream
e¡ector other than ERK1 that was used for the
read-out of A-Raf activation. In our experiment we
also isolated some EST that might be a candidate for
the new partner of MEK2. GenBank reports indicate
that they are similar to Raf, Ksr or MEK2. This
showed that there might still exist unrecognized iso-
forms in the MAP kinase pathway.
Our results showed that MEK2 could be a new
partner of A-Raf, but it remains to be determined
whether A-Raf could phosphorylate MEK2 and
whether A-Raf activated MEK2 had a speci¢c e¡ec-
tor other than ERK1.
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